Tennessee SB1848 amends state law to allow healthcare providers to administer buprenorphine products for substance use disorder treatment.
Tennessee SB1848 modifies Tennessee Code Annotated, Title 53, Chapter 11, to allow healthcare providers to administer buprenorphine products directly for the treatment of substance use disorder. This change permits the use of buprenorphine mono or buprenorphine without naloxone, provided it is administered by a healthcare provider within their scope of practice and not dispensed for administration away from the premises.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.